Biocompatibility Tests Added As Special Control For IVF Downclassification
This article was originally published in The Gray Sheet
Executive Summary
FDA's final rule downclassifying from Class III to Class II (special controls) nine in vitro fertilization and related assisted reproduction devices does not allow for voluntary compliance to standards developed by the College of American Pathologists and the Society for Assisted Reproductive Technology.
You may also be interested in...
PGD Intended Use Limitations Addressed In FDA Warning Letter
Mid-Atlantic Diagnostics says it will take steps to clarify the intended use of its Stripper micropipette, following a warning letter requiring the firm to submit a 510(k) for pre-implantation genetic diagnosis claims
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.